Cesarean. Disruption of caesarean section wound
Conditions
Interventions
Intervention 1: Intervention group 1: The silver nano-particles spray (Nyvasha) is put at a distance of 10 cm from caesarian wound
three puffs are sprayed on the beginning, middle and end of the wound respectively. Twice a day for 10 consecutive days, and each time 3 puffs, is prescribed. Intervention 2: Intervention group 2: Spr
Treatment - Drugs
Placebo
Intervention group 1: The silver nano-particles spray (Nyvasha) is put at a distance of 10 cm from caesarian wound
three puffs are sprayed on the beginning, middle and end of the wound respectively. Twice a day for 10 consecutive days, and each time 3 puffs, is prescribed.
Intervention group 2: Spray serum that contains a simple base wash (placebo) is put on caesarean section wound at a distance of 10 cm from the wound. Three puffs are sprayed on the beginning, middle a
Control group: Control group do not receive any drugs
Sponsors
Ethics committee of Mashhad University of Medical Scienes
Eligibility
Sex/Gender
Female
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria include: Patient's consent to participate in this study; have minimum level of literacy; Iranian; term pregnancy (37-42 weeks); 18 to 35 years of age; cesarean with beneath cut; initial cesarean section; body mass index in the range of 18.5-25 in early pregnancy; no complications of pregnancy (eclampsia, preclampsia , corioamniotitis, twin pregnancy, poly hydroamnios ); no acute or chronic illness; no-disruptive healing (disease i.e diabetes, kidney disease, anemia, liver disease, mental; not having any abnormality in the fetus ; non-consumption of drugs and tobacco; non-use of drugs affecting wound healing (glucocorticoids, anticoagulants, immunosuppressant drugs and chemotherapy). Exclusion criteria include: Unwillingness to continue cooperation; major bleeding or need for blood transfusion, hysterectomy and myomectomy with cesarean section; prolonged operation for more than 60 minutes; wound infection; irregular spray use and as directed; complications arising from the use of spray; infancy in NICU.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Wound healing. Timepoint: After cesarean section (24 ±4 hours) and 5th and 10th days after the caesarian section. Method of measurement: Reeda Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: After cesarean section (24 ±4 hours) and 5th and 10th days after the caesarian section. Method of measurement: Pain visual analog scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZakieh Boroumand
Mashhad University of Medical Sciences
Outcome results
None listed